How Much Did Abtrace Raise?
Funding & Key Investors

Abtrace, a health technology company leveraging machine learning for chronic condition management, has secured significant enterprise-level funding, with the total capital raised standing at $2.9M. The company recently announced a major strategic investment of $2.9M, underscoring its progress in developing advanced solutions for detecting, monitoring, and treating long-term health issues. This latest financing round is expected to accelerate Abtrace's growth and market penetration.

What is Abtrace?

Abtrace
SoftwareHealthcare SoftwareBusiness Services

Abtrace operates at the intersection of health technology and artificial intelligence, utilizing sophisticated machine learning algorithms to address the complexities of chronic and long-term health conditions. Based in London, United Kingdom, the company aims to revolutionize patient care by providing tools for early detection, continuous monitoring, and effective treatment strategies. Their innovative approach targets a critical need within the healthcare sector for more proactive and personalized health management solutions.

How much funding has Abtrace raised?

Abtrace has raised a total of $2.9M across 1 funding round:

2021

Angel/Seed

$2.9M

Angel/Seed (2021): $2.9M with participation from Ganexa Capital and Faber SpA

Key Investors in Abtrace

Ganexa Capital

Ganexa Capital is a business angel firm that invests time and money in entrepreneurial projects, particularly those with a technological focus that aim to address unmet market needs. They partner closely with entrepreneurs, leveraging their expertise and resources to help overcome obstacles and achieve global aspirations.

Faber SpA

For fifty years we have created, designed and manufactured hoods to become an industrial reality occupying a key position in production and technology globally. This is why we are leaders in the sector. For this reason, in Italy, one hood out of two is a Faber hood. We are an industrial group present globally in 8 nations and 3 continents with our production and commercial sites.

What's next for Abtrace?

With the recent infusion of capital, Abtrace is poised for a significant expansion phase. The company is likely to focus on scaling its technological infrastructure, enhancing its machine learning capabilities, and broadening its market reach. This strategic investment signals strong confidence from backers in Abtrace's potential to disrupt the health tech landscape and improve patient outcomes globally. Future developments may include strategic partnerships and further product development to solidify its position as a leader in AI-driven healthcare.

See full Abtrace company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Content & Collaboration SoftwareSoftwareEducationTraining
Financial SoftwareSoftware
Financial SoftwareSoftware
Security SoftwareSoftware

Frequently Asked Questions Regarding Abtrace Financial Insights

What are the most recent funding rounds that Abtrace has completed, and what were the funding rounds?
Abtrace has recently completed 1 funding rounds: Angel/Seed on Aug 26, 2021.
What is the total amount of funding Abtrace has raised to date?
Abtrace has raised a total of $2.9M in funding to date.
How many funding rounds has Abtrace completed?
Abtrace has completed 1 funding rounds.
How much funding did Abtrace raise in its most recent funding round?
Abtrace raised $2.9M in its most recent funding round.
Who are the lead investors in Abtrace's latest funding round?
The lead investor in Abtrace's latest funding round was Ganexa Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Abtrace's history?
The largest funding round in Abtrace's history was $2.9M.
See more information about Abtrace